Logistics giants are investing heavily to expand their cold storage capabilities in response to the growing demand for temperature-sensitive pharmaceuticals, such as GLP-1s, according to CNBC. This increased demand is driven by the healthcare boom, which has highlighted the need for reliable and efficient cold chain distribution. As a result, companies are racing to keep up with the rapidly changing landscape of pharmaceutical distribution.
The expansion of cold storage facilities is expected to rewrite the distribution strategy for pharmaceutical companies, with companies like Cencora investing in specialty infrastructure to meet the growing demand, as reported by Seeking Alpha. Pharmaceutical Commerce also notes that specialty growth and cold chain demand are driving changes in distribution strategy. However, specific details on the scale of investment and expansion plans are limited.
The need for cold storage is critical in the pharmaceutical industry, particularly for temperature-sensitive medicines like GLP-1s, which require strict temperature controls to maintain their efficacy. The healthcare boom has accelerated the demand for these medicines, making reliable cold chain distribution a key factor in the industry.